Xeris Biopharma Holdings, Inc.

XERS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001867096

SEC filings (opens in a new tab)

In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of XERS: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	144	1	162	+19
Shares	63.9M	42.1K	65.6M	+1.68M (+2.6%)
Value	$182.2M	$119.9K	$222.2M	+$40.2M (+22.1%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to XERS in Q4 2024
Institution	Shares	Value	% of portfolio
Citadel Advisors LLC	833,328	$2.82M	0.00%
Driehaus Capital Management LLC	594,015	$2.01M	0.02%
Essex Investment Management Co LLC	474,955	$1.61M	0.29%
EAM Investors, LLC	222,377	$753.9K	0.11%
Stonepine Capital Management, LLC	182,317	$618.1K	0.50%
Legato Capital Management LLC	142,164	$481.9K	0.06%
Globeflex Capital L P	125,210	$424.5K	0.04%
Roundview Capital LLC	120,000	$406.8K	0.03%
BNP Paribas Arbitrage, SA	100,012	$339.0K	0.00%
Rossby Financial, LCC	35,000	$118.7K	0.08%
Police & Firemen's Retirement System of New Jersey	31,659	$107.3K	0.00%
Jump Financial, LLC	28,784	$97.6K	0.00%
Sherbrooke Park Advisers LLC	23,326	$79.1K	0.03%
Sunpointe, LLC	21,000	$71.2K	0.04%
Virtus ETF Advisers LLC	20,910	$70.9K	0.03%
HRT Financial LP	20,672	$70.0K	0.00%
Susquehanna Fundamental Investments, LLC	19,712	$66.8K	0.00%
Balyasny Asset Management LLC	17,153	$58.1K	0.00%
Virtu Financial LLC	17,137	$58.0K	0.00%
Aquatic Capital Management LLC	14,684	$49.8K	0.00%
Two Sigma Advisers, LP	13,741	$46.6K	0.00%
Raymond James Financial Inc	13,150	$44.6K	0.00%
CIBC World Markets Corp	13,123	$44.5K	0.00%
R Squared Ltd	12,320	$41.8K	0.04%
GWM Advisors LLC	10,000	$10.7K	0.00%
GF Fund Management Co. Ltd.	3,130	$10.6K	0.00%
SBI Securities Co., Ltd.	1,917	$6.50K	0.00%
Truvestments Capital LLC	847	$2.87K	0.00%
Spurstone Advisory Services, LLC	200	$678	0.01%
Caitong International Asset Management Co., Ltd	186	$631	0.00%
WealthTrak Capital Management LLC	40	$136	0.00%

Sold out (12)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of XERS in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Walleye Capital LLC	1,121,738	$3.20M
ExodusPoint Capital Management, LP	84,740	$242.0K
Boothbay Fund Management, LLC	34,710	$98.9K
Quantbot Technologies LP	15,425	$44.0K
Stoneridge Investment Partners LLC	15,028	$43.0K
XTX Topco Ltd	13,890	$39.6K
Picton Mahoney Asset Management	1,015	$3.00K
Spectrum Wealth Counsel, LLC	834	$2.38K
Comerica Bank	611	$1.74K
Allspring Global Investments Holdings, LLC	607	$1.73K
American Capital Advisory, LLC	50	$143
Danske Bank A/S	2	$6

Not filed for Q4 2024 yet (1)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XERS in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Raymond James & Associates	42,062	$119.9K